948883-29-2 Usage
Uses
Used in Pharmaceutical Synthesis:
Imidazo[1,2-a]pyridine-6-propanenitrile, b-oxoserves as a key intermediate in the creation of various pharmaceuticals. Its unique structure allows it to be a component in the development of drugs targeting a range of diseases.
Used in Industrial Chemical Production:
Beyond its pharmaceutical applications, Imidazo[1,2-a]pyridine-6-propanenitrile, b-oxois also utilized in the synthesis of industrial chemicals. Its versatility in chemical reactions makes it valuable for a variety of commercial applications.
Used in Antiviral Applications:
Imidazo[1,2-a]pyridine-6-propanenitrile, b-oxohas been studied for its potential as an antiviral agent. It may be used in the development of treatments for viral infections due to its ability to interfere with viral replication cycles.
Used in Antibacterial Applications:
Imidazo[1,2-a]pyridine-6-propanenitrile, b-oxoalso holds promise in the realm of antibacterial drugs. Its potential to combat bacterial infections is currently under investigation, with the aim of developing new antibiotics to address the growing issue of antibiotic resistance.
Used in Anticancer Applications:
Research into the anticancer properties of Imidazo[1,2-a]pyridine-6-propanenitrile, b-oxois ongoing. It may be employed as a chemotherapeutic agent or in the development of targeted cancer therapies, providing new options for cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 948883-29-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,8,8,8 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 948883-29:
(8*9)+(7*4)+(6*8)+(5*8)+(4*8)+(3*3)+(2*2)+(1*9)=242
242 % 10 = 2
So 948883-29-2 is a valid CAS Registry Number.
948883-29-2Relevant academic research and scientific papers
ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR INHIBITORS
-
Page/Page column 56-57; 60, (2010/04/03)
The present invention provides compounds and compositions, methods of making them, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can a
SYNTHESIS OF PYRAZOLES
-
Page/Page column 39-40; 43, (2009/08/16)
The present invention provides methods of making HCl salts, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other
NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS
-
Page/Page column 41, (2008/12/07)
The present invention provides compounds of formula (I) and compositions thereof, methods of making them, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.
MODULATORS OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTORS AND THERAPEUTIC USES THEREOF
-
Page/Page column 46, (2010/11/28)
Compounds with α7 nicotinic acetylcholine receptor (α7 nAChR) agonistic activity, processes for their preparation, pharmaceutical compositions containing the same and the use thereof for the treatment of neurological and psychiatric diseases.
